Lymphoma Clinical Trials in Aarhus
7 recruitingAarhus, Denmark
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Loxo Oncology, Inc.249 enrolled133 locationsNCT06588478
Recruiting
Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Hodgkin Lymphoma
University College, London1,042 enrolled69 locationsNCT04685616
Recruiting
Phase 3
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Lymphoma
SecuraBio124 enrolled43 locationsNCT06522737
Recruiting
Not Applicable
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
Anthracycline-induced Cardiac ToxicityLymphoma
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III608 enrolled24 locationsNCT05223413
Recruiting
Not Applicable
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
Acute Myeloid LeukemiaMultiple MyelomaLymphoma+1 more
Christoffer Johansen920 enrolled7 locationsNCT05444348
Recruiting
Phase 3
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Lymphoblastic Lymphoma, Childhood
University Hospital Muenster683 enrolled228 locationsNCT04043494
Recruiting
Phase 3
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Diffuse Large B Cell LymphomaDLBCL
Nordic Lymphoma Group300 enrolled69 locationsNCT04332822